C4X Discovery Holdings PLC

PatientSeek identifies a genetic signature that separates integrin a4b7 therapy responders from non-responders in inflammatory bowel disease.

C4X Discovery Holdings Limited PatientSeek identifies a segregating genetic signature a4bRole of 7 integrin therapy and the non-responder population in…